This sex-specific combination urinary biomarker panel also showed 86.7% sensitivity, 61.4% specificity and 73.8% accuracy (Supplementary Table S4), which showed much higher sensitivity than conventional serum tumour markers, CEA (15.0%) and CA19-9 (16.8%). Here, CEACAM5 is linked to neoplasm.